Ligand validation:7VU0

DMU: DECYL-BETA-D-MALTOPYRANOSIDE

DMU is a Ligand Of Interest in 7VU0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7VU0_DMU_A_501	84%	35%	0.079	0.964	1.62	1.06	8	2	0	0	88%	0.8788
7VU0_DMU_B_502	83%	32%	0.085	0.964	1.55	1.27	9	3	0	0	88%	0.8788
7VU0_DMU_A_502	71%	33%	0.08	0.95	1.61	1.18	4	3	1	0	73%	0.7273
7VU0_DMU_B_501	69%	31%	0.088	0.951	1.7	1.15	7	2	0	0	73%	0.7273
7VU1_DMU_B_502	77%	34%	0.091	0.953	1.54	1.15	6	4	0	0	88%	0.8788
6PW0_DMU_A_608	86%	26%	0.098	0.967	1.89	1.24	9	4	1	0	100%	1
6PW1_DMU_A_612	86%	28%	0.087	0.955	1.78	1.24	9	5	0	0	100%	1
3FYI_DMU_A_573	85%	61%	0.089	0.956	0.51	0.94	-	3	0	0	100%	1
3OMI_DMU_B_301	85%	65%	0.096	0.96	0.45	0.88	-	2	0	0	100%	1
7COH_DMU_A_526	82%	45%	0.09	0.946	1.05	1.12	2	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.